Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (311-320 of 564) with videos related to

Pageof 57
Sort By:
Psycho-Oncology|September 10, 2014
Distress in suspected lung cancer patients following rapid and standard diagnostic programs: a prospective observational studyPepijn Brocken, Erik H F M van der Heijden, Karen T M Oud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2012
A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutationAnne-Marie C Dingemans, Wouter W Mellema, Harry J M Groen, et al.
Stroke|June 13, 2015
Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage StudyCarlina E van Donkelaar, Nicolaas A Bakker, Nic J G M Veeger, et al.
Cancers|January 5, 2018
Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung CancersJiacong Wei, Anthonie J van der Wekken, Ali Saber, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2024
The prediction of treatment outcome in NSCLC patients harboring an EGFR exon 20 mutation using molecular modelingF Zwierenga, L Zhang, J Melcr, et al.
British Journal of Cancer|July 5, 2007
Irradiation of rat brain reduces P-glycoprotein expression and functionJ Bart, W B Nagengast, R P Coppes, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinibLeora Horn, Scott Gettinger, D Ross Camidge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2011
Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 yearsMiep A van der Drift, Henrike E Karim-Kos, Sabine Siesling, et al.
Clinical Lung Cancer|July 2, 2016
Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung CancerMilind Pore, Coby Meijer, Geertruida H de Bock, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 12, 2026
Characteristics and effects of depth of anaesthesia on late motor responsesM C Gadella, M Sahinovic, C H M Scholtens-Henzen, et al.
Pageof 57

Showing results (311-320 of 564) with videos related to

Sort By:
Pageof 57
Psycho-Oncology|September 10, 2014
Distress in suspected lung cancer patients following rapid and standard diagnostic programs: a prospective observational studyPepijn Brocken, Erik H F M van der Heijden, Karen T M Oud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2012
A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutationAnne-Marie C Dingemans, Wouter W Mellema, Harry J M Groen, et al.
Stroke|June 13, 2015
Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage StudyCarlina E van Donkelaar, Nicolaas A Bakker, Nic J G M Veeger, et al.
Cancers|January 5, 2018
Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung CancersJiacong Wei, Anthonie J van der Wekken, Ali Saber, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2024
The prediction of treatment outcome in NSCLC patients harboring an EGFR exon 20 mutation using molecular modelingF Zwierenga, L Zhang, J Melcr, et al.
British Journal of Cancer|July 5, 2007
Irradiation of rat brain reduces P-glycoprotein expression and functionJ Bart, W B Nagengast, R P Coppes, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinibLeora Horn, Scott Gettinger, D Ross Camidge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2011
Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 yearsMiep A van der Drift, Henrike E Karim-Kos, Sabine Siesling, et al.
Clinical Lung Cancer|July 2, 2016
Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung CancerMilind Pore, Coby Meijer, Geertruida H de Bock, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 12, 2026
Characteristics and effects of depth of anaesthesia on late motor responsesM C Gadella, M Sahinovic, C H M Scholtens-Henzen, et al.
Pageof 57